- Home
- AUPH vs OMCL Comparison
AUPH vs OMCL Comparison
Compare AUPH & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- OMCL
- Stock Information
- Founded
- AUPH 1993
- OMCL 1992
- Country
- AUPH Canada
- OMCL United States
- Employees
- AUPH 300
- OMCL N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- OMCL Computer Manufacturing
- Sector
- AUPH Health Care
- OMCL Technology
- Exchange
- AUPH Nasdaq
- OMCL Nasdaq
- Market Cap
- AUPH 1.2B
- OMCL 1.3B
- IPO Year
- AUPH 1999
- OMCL 2001
- Fundamental
- Price
- AUPH $8.93
- OMCL $28.27
- Analyst Decision
- AUPH Strong Buy
- OMCL Buy
- Analyst Count
- AUPH 2
- OMCL 6
- Target Price
- AUPH $11.50
- OMCL $45.33
- AVG Volume (30 Days)
- AUPH 2.1M
- OMCL 453.6K
- Earning Date
- AUPH 07-31-2025
- OMCL 07-31-2025
- Dividend Yield
- AUPH N/A
- OMCL N/A
- EPS Growth
- AUPH N/A
- OMCL N/A
- EPS
- AUPH 0.27
- OMCL 0.45
- Revenue
- AUPH $247,295,000.00
- OMCL $1,135,755,000.00
- Revenue This Year
- AUPH $12.15
- OMCL $3.84
- Revenue Next Year
- AUPH $18.34
- OMCL $3.98
- P/E Ratio
- AUPH $33.57
- OMCL $62.42
- Revenue Growth
- AUPH 29.20
- OMCL 3.00
- 52 Week Low
- AUPH $5.20
- OMCL $22.66
- 52 Week High
- AUPH $10.67
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- AUPH 57.25
- OMCL 46.95
- Support Level
- AUPH $8.73
- OMCL $27.80
- Resistance Level
- AUPH $9.37
- OMCL $28.91
- Average True Range (ATR)
- AUPH 0.41
- OMCL 0.91
- MACD
- AUPH 0.04
- OMCL 0.00
- Stochastic Oscillator
- AUPH 77.28
- OMCL 42.51
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.